Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of…
Read More »
SPARC Health, a collaborative effort between Park City Angels (PCA),…
Taking place on March 12, 2026, at the Hilton Salt…
Check out the photo gallery from the 2026 JP Morgan…
The purchase is expected to expand Haemonetics’ impact in fast-growing…
State-of-the-art, multi-modality breast biopsy system slated to be in the…
DiscGenics Treats First Patient in Phase 3 Clinical Trial of…
Published in the journal PREGNANCY, the PRIME Study demonstrates significant…
Fluidx GPX Embolic Device Pivotal Trial Completes Enrollment
Dr. Mark Davis, discoverer of the first T-cell receptor genes…
Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read…
As we look back at 2025, we’re thankful for the…
The New England Journal of Medicine Publishes Phase 1/2 Study…
2025 marked a year of significant progress of reached milestones…
A microbiologist, Adam Barker, PhD, was ARUP’s chief scientific officer…
The Australian patent represents the first patent granted for the…
Merit Medical’s Fred Lampropoulos Honored by Nasdaq
Perimeter Solutions Announces Agreement to Acquire MMT for $685 Million
Freyya Recognized at Transatlantic Angel Competition (TAAC8)
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced…
Notifications
